Literature DB >> 24552196

Integrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma.

Yurie Soejima1, Masafumi Inoue, Yoshihisa Takahashi, Hiroshi Uozaki, Motoji Sawabe, Toshio Fukusato.   

Abstract

AIM: The aim of this study was to evaluate integrin expression and immunolocalization of the extracellular matrix proteins in cholangiolocellular carcinoma (CoCC).
METHODS: Tissue specimens of 23 CoCC, 28 cholangiocarcinomas (CCC), 42 hepatocellular carcinomas (HCC) and 11 classical type combined hepatocellular cholangiocarcinomas (CHC) were immunostained for β6, β4 and α3 integrins, fibronectin and laminin. ITGB6, B4 and A3 mRNA levels in six HCC cell lines, five CCC cell lines and two CHC cell lines were quantified by quantitative reverse transcription polymerase chain reaction.
RESULTS: Little or no positivity for β6, β4 and α3 integrins was shown in 91%, 91% and 52% of CoCC and 100%, 98% and 81% of HCC, respectively, according to immunostaining, whereas intense positive staining for these integrins was demonstrated in 64%, 96% and 75% of CCC, respectively. There was a close correlation between β4 and α3 integrin expression and intracytoplasmic laminin in CoCC, CCC and HCC, but not between β6 expression and its ligand, fibronectin. Integrin mRNA levels were increased in four of five CCC cell lines, but nearly undetectable in five of six HCC cell lines and one CHC cell line. Tubular differentiation of a CHC cell line cultured in collagen gel matrix induced upregulation of these integrins.
CONCLUSION: Our results first indicated downregulation of αvβ6, α6β4 and α3β1 integrins in CoCC, in contrast to its high expression in CCC, suggesting a diagnostic value of integrins in the differential diagnosis of CoCC and CCC, as well as a useful inducible marker of the intermediate features of CoCC.
© 2014 The Japan Society of Hepatology.

Entities:  

Keywords:  cholangiocarcinoma; cholangiolocellular carcinoma; hepatocellular carcinoma; integrin; laminin; stem cell features

Year:  2014        PMID: 24552196     DOI: 10.1111/hepr.12312

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  8 in total

1.  Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Authors:  Jennifer Owens; Heather Francis
Journal:  Hepat Oncol       Date:  2015-07-30

2.  Vitronectin-Based, Biomimetic Encapsulating Hydrogel Scaffolds Support Adipogenesis of Adipose Stem Cells.

Authors:  Tracy N Clevenger; Cassidy R Hinman; Rebekah K Ashley Rubin; Kate Smither; Daniel J Burke; Craig J Hawker; Darin Messina; Dennis Van Epps; Dennis O Clegg
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

3.  Role of laminin and cognate receptors in cholangiocarcinoma cell migration.

Authors:  Kittiya Islam; Parichut Thummarati; Pakkanun Kaewkong; Banchob Sripa; Tuangporn Suthiphongchai
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

4.  Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.

Authors:  Yaqing Chen; Dan Liu; Pengfei Liu; Yajing Chen; Huiling Yu; Quan Zhang
Journal:  Mol Med Rep       Date:  2017-01-16       Impact factor: 2.952

Review 5.  Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors.

Authors:  Yoshihisa Takahashi; Erdenetsogt Dungubat; Hiroyuki Kusano; Dariimaa Ganbat; Yasuhiko Tomita; Sarandelger Odgerel; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

6.  ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression.

Authors:  Yurie Soejima; Miho Takeuchi; Nao Miyamoto; Motoji Sawabe; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

7.  β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma.

Authors:  Yurie Soejima; Miho Takeuchi; Takumi Akashi; Motoji Sawabe; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2018-03-27       Impact factor: 5.923

Review 8.  Molecular Targets in Hepatocarcinogenesis and Implications for Therapy.

Authors:  Meng-Yu Wu; Giuo-Teng Yiang; Pei-Wen Cheng; Pei-Yi Chu; Chia-Jung Li
Journal:  J Clin Med       Date:  2018-08-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.